RoundTable
Healthcare Partners, an operating-oriented private equity firm focused
exclusively on the healthcare industry, announced today that its portfolio
company, Renaissance Pharma Inc., has acquired Confab Laboratories Inc. Confab
is a leading contract pharmaceutical manufacturer in St. Hubert, located on the
south shore of Montreal,
Québec, Canada.
“Renaissance
is excited by the opportunity to further invest in the continued growth and
success of Confab,” said Pierre Fréchette, President and CEO of Renaissance. “As part of Renaissance, we are committed to
supporting Confab’s mandate as a unique, fully-integrated pharmaceutical
contract manufacturer.”
“RoundTable and Renaissance are ideal partners
for Confab,” said Guy Lamarre, founder and former CEO of Confab. “Their collective industry experience will be
instrumental in building on existing partnerships with current customers and
developing strong relationships with new ones.”
Mr.
Lamarre will remain active in future development of the business as
Vice-Chairman of Renaissance.
Accordingly, Nathalie Brisson has been promoted to the position of
President and General Manager of Confab and will assume leadership of the
day-to-day business operations along with the other members of the existing
management team.
“RoundTable is pleased to be working with
Renaissance and Confab on this new venture,” stated James E. Utts, Jr., an
Operating Partner at RoundTable and the Chairman of the Board of Renaissance.
“We remain enthusiastic about opportunities in the pharmaceutical
market and are excited to move forward in support of the Confab team.”
